General information
  • Disease category Other (BASEC)
  • Recruitment status recruitment not started yet (BASEC/ICTRP)
  • Trial sites
    St. Gallen
    (BASEC)
  • Contact Alexander Dullenkopf alexander.dullenkopf@stgag.ch (BASEC)
  • Data Source(s) BASEC: Import from 26.06.2025 ICTRP: N/A
  • Last update 26.06.2025 12:10
HumRes66976 | SNCTP000006439 | BASEC2025-D0055

Insertion of the Singularity airway device with or without muscle relaxants

  • Disease category Other (BASEC)
  • Recruitment status recruitment not started yet (BASEC/ICTRP)
  • Trial sites
    St. Gallen
    (BASEC)
  • Contact Alexander Dullenkopf alexander.dullenkopf@stgag.ch (BASEC)
  • Data Source(s) BASEC: Import from 26.06.2025 ICTRP: N/A
  • Last update 26.06.2025 12:10

Summary description of the study

Laryngeal masks are commonly used airway devices in anesthesia. Singularity is a newly introduced laryngeal mask that has already been studied in our department in 2 studies. Muscle relaxants are also frequently used in anesthesia in connection with airway management, for example during intubation. This study aims to investigate whether the insertion of the Singularity is facilitated by the administration of muscle relaxants. 90 patients will be randomized into 2 groups (insertion with or without muscle relaxant). One inclusion criterion is that the medication is deemed necessary for the operation. The main parameter being investigated is the time required for the insertion of the laryngeal mask.

(BASEC)

Intervention under investigation

Laryngeal mask Singularity (Singularity; Schönenberg, Switzerland)

(BASEC)

Disease under investigation

Patients in general anesthesia with laryngeal mask as airway assistance

(BASEC)

Criteria for participation in trial
Patient consent, age > 18 years, weight 50 - 100 kg, planned anesthesia with laryngeal mask, muscle relaxants deemed necessary (BASEC)

Exclusion criteria
Pregnancy, emergency surgery, loose teeth, patient refusal (BASEC)

Trial sites

St. Gallen

(BASEC)

not available

Sponsor

Institut für Anästhesie, Spital Thurgau Frauenfeld

(BASEC)

Contact

Contact Person Switzerland

Alexander Dullenkopf

+41581447560

alexander.dullenkopf@stgag.ch

Spital Thurgau Frauenfeld

(BASEC)

Scientific Information

not available

Name of the authorising ethics committee (for multicentre studies, only the lead committee)

Ethikkommission Ostschweiz EKOS

(BASEC)

Date of authorisation

12.06.2025

(BASEC)


ICTRP Trial ID
not available

Official title (approved by ethics committee)
Prospective evaluation of the Laryngeal Mask Singularity® in adult patients with or without neuromuscular blockade under clinical conditions (BASEC)

Academic title
not available

Public title
not available

Disease under investigation
not available

Intervention under investigation
not available

Type of trial
not available

Trial design
not available

Inclusion/Exclusion criteria
not available

not available

Primary and secondary end points
not available

not available

Registration date
not available

Incorporation of the first participant
not available

Secondary sponsors
not available

Additional contacts
not available

Secondary trial IDs
not available

Results-Individual Participant Data (IPD)
not available

Further information on the trial
not available

Results of the trial

Results summary

not available

Link to the results in the primary register

not available